These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17338268)

  • 21. Mechanism of antigenic variation in Shigella flexneri bacilli. IV. Role of lipopolysaccharides and their components in the sensitivity of Shigella flexneri 1b and its Lac+ recombinant to killing action of serum.
    Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):235-42. PubMed ID: 9597093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
    Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK; Inzana TJ
    J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanisms of complement activation in normal bovine serum and normal horse serum against Yersinia enterocolitica O:9 strains with different outer membrane proteins content.
    Miętka K; Brzostek K; Guz-Regner K; Bugla-Płoskońska G
    Pol J Vet Sci; 2016; 19(1):99-107. PubMed ID: 27096793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States.
    Trebicka E; Jacob S; Pirzai W; Hurley BP; Cherayil BJ
    Clin Vaccine Immunol; 2013 Oct; 20(10):1491-8. PubMed ID: 23803904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The efficiency of the bactericidal action of serum raised by complement and lysozyme against bacteria which avoid the immunological response of higher organisms].
    Futoma-Kołoch B; Bugla-Płoskońska G
    Postepy Hig Med Dosw (Online); 2009 Oct; 63():471-84. PubMed ID: 19850971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Tool for Complement Research:
    Mutti M; Ramoni K; Nagy G; Nagy E; Szijártó V
    Front Immunol; 2018; 9():2770. PubMed ID: 30564230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.
    O'Hara AM; Moran AP; Würzner R; Orren A
    Immunology; 2001 Mar; 102(3):365-72. PubMed ID: 11298837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish (Ictalurus punctatus).
    Ourth DD; Bachinski LM
    Dev Comp Immunol; 1987; 11(3):551-64. PubMed ID: 3678558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal activity of normal human serum against Morganella, Proteus, and Providencia strains.
    Nawrot U; Mokracka-Latajka G; Grzybek-Hryncewicz J; Krzyzanowska B; Jankowski S
    Acta Microbiol Pol; 1995; 44(1):55-61. PubMed ID: 7660859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.
    Merino S; Camprubí S; Tomás JM
    J Gen Microbiol; 1991 Jul; 137(7):1583-90. PubMed ID: 1955853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against Citrobacter braakii O37 cells recognize the N-glycan of the band 3 glycoprotein of human erythrocyte membrane.
    Ebaid H; Duk M; Gamian A
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):352-61. PubMed ID: 18266742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The factor C3 conversion in human complement by smooth Shigella flexneri lipopolysaccharides.
    Fudała R; Doroszkiewicz W; Niedbach J; Gamian A; Weintraub A; Kaca W
    Acta Microbiol Pol; 2003; 52(1):45-52. PubMed ID: 12916727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum susceptibility of coliforms isolated from bovine intramammary infections.
    Hogan JS; Todhunter DA; Smith KL; Schoenberger PS
    J Dairy Sci; 1989 Jul; 72(7):1893-9. PubMed ID: 2674230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunopathological evidence of terminal residues containing sialic acid in Campylobacter jejuni lipopolysaccharide as the critical antigen to induce peripheral neuropathy].
    Xiang SL; Cai FC; Zhang XP; Deng B
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):665-70. PubMed ID: 16191299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The susceptibility of gram-negative rods and their adaptive forms resistant to colistine to the bactericidal action of sera.
    Doroszkiewicz W; Cisowska A; Jankowski S; Koziorowski A; Murawski M
    Acta Microbiol Pol; 1998; 47(3):275-81. PubMed ID: 9990711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.